No. 2.34 (2014)

Published: 2016-11-10

Review

Лечение пациентов с артериальной гипертензией в 2014 г.: возможности телмисартана

A.E. Bagriy

51-56
- PDF (Русский)
Снижение риска цереброваскулярных заболеваний у пациентов с артериальной гипертензией

Ye.G. Nesukay

59-65
- PDF (Русский)

Clinical Researches

Risk Stratification of Patients with Hypertension and Type 2 Diabetes Mellitus: Results of Ukrainian Multicenter Observational Study STATUS

Yu.N. Sirenko, A.D. Radchenko, T.G. Slascheva

9-19
- PDF (Русский)
Profile of Risk Factors for Cardiovascular Diseases Among Men Who Work Under the Influence of Electromagnetic Radiation of Microwave Range

М.М. Selyuk, V.S. Potaskalova

20-26
- PDF (Українська)
Pilot Study of Resveratrol Impact Compared with Rosuvastatin and Their Combination on Lipid Profile in Patients with Essential Hypertension

Yu.N. Sirenko, S.N. Kushnir, G.V. Ponomareva

35-44
- PDF (Русский)
Evaluation of Antihypertensive and Cardioprotective Efficacy of Indapamide as Monotherapy in Patients with Mild to Moderate Hypertension

L.Sh. Khafizova, G.A. Khamidullayeva, N.Z. Srozhidinova, G.Zh. Abdullayeva, N.Sh. Shakirova, N.B. Tursunova

45-50
- PDF (Русский)

Postgraduate Education

Do We Need Arguments Concerning What is Better, Sartans or ACE Inhibitors? (Part 1)

A.D. Radchenko

97-111
- PDF (Русский)